ED
EVER icon

Exane Derivatives’s EverQuote EVER Stock Holding History

Exane Derivatives’s Portfolio EVER Stock Details EVER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,155
Closed -$77.4K – 910
2021
Q3 		$77.4K Buy
4,155
+2,901
+231% +$69.4K 0.02% 565
2021
Q2 		$37K Buy
1,254
+1,215
+3,115% +$40.5K 0.01% 665
2021
Q1 		$1.42K Buy
+39
New +$1.66K ﹤0.01% 706

Other funds holding EVER

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Exane Derivatives's EVER Position: Q4 2021 in Review

Exane Derivatives sold out of EverQuote (EVER) in Q4 2021, closing a stake of 4,155 shares — an estimated $77.4K sold.

Exane Derivatives first reported a position in EVER in Q1 2021 and held it in 3 quarters. The position peaked at $77.4K in Q3 2021. 121 funds tracked by Wall St. Rank hold EVER as of Q4 2021.

  • Exane Derivatives reported no remaining EverQuote position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 4,155 EverQuote shares in Q4 2021, an estimated $77.4K.
  • Exane Derivatives first reported a position in EverQuote in Q1 2021 and held it in 3 quarters.
  • Exane Derivatives's EverQuote position peaked at $77.4K in Q3 2021.
  • 121 funds tracked by Wall St. Rank held EverQuote as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.